Patents by Inventor Yingui Li

Yingui Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220324932
    Abstract: The present application provides a modified interleukin-2 (IL-2) protein comprising an engineered glutamine (Q) residue. The present application also provides a modified IL-2 protein-polyethylene glycol (PEG) conjugate comprising a modified IL-2 protein comprising an engineered Q residue and a PEG moiety, wherein the PEG moiety is conjugated to the modified IL-2 protein via the engineered Q residue. Pharmaceutical compositions, kits, methods of making, and methods of treatment (e.g., for cancer) are also provided.
    Type: Application
    Filed: June 18, 2020
    Publication date: October 13, 2022
    Inventors: Zhe YAN, Lixin FENG, Yingui LI
  • Publication number: 20110245334
    Abstract: Use of a racemate of pinocembrin, a racemate of pinocembrin salt, a racemate of pinocembrin precursor or a racemate of pinocembrin hydrate in manufacture of a medicament for prophylaxis and treatment of stroke. Particularly, use of pinocembrin racemate in manufacture of a medicament for treatment of acute ischemic stroke.
    Type: Application
    Filed: December 10, 2009
    Publication date: October 6, 2011
    Applicant: CSPC Zhonggi Pharmaceutical Technology (Shijiazhuang) Co. Ltd.
    Inventors: Guanhua Du, Jinxu Wang, Song Wu, Ying Shi, Mei Gao, Yingui Li, Yan Qi, Dongmin Shen, Hongmei Guang, Haili Liu, Rui Liu, Xiaolong Feng